🏛️ Verified NIH Record • Updated 2025-08-26
OCS™ Lung TOP Registry For Donor Lungs for Transplantation (NCT03639025)
The Organ Care System (OCS™) Lung Thoracic Organ Perfusion (TOP) Registry for Donor Lungs for Transplantation
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: TransMedics
🩺 Plain-English Summary (8th-Grade Level)
Single-arm, prospective, multi-center, post-approval U.S. registry
Who can join: Review the eligibility criteria below.
Location: St. Joseph's Hospital and Medical Center — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- St. Joseph's Hospital and Medical Center — Phoenix, Arizona
- UCLA — Los Angeles, California
- Stanford University — Palo Alto, California
- UCSF — San Francisco, California
- Tampa General Hospital — Tampa, Florida
- Emory — Atlanta, Georgia
- University of Chicago — Chicago, Illinois
- Johns Hopkins — Baltimore, Maryland
- Massachusetts General Hospital — Boston, Massachusetts
- Henry Ford Health System — Detroit, Michigan
- University of Minnesota — Minneapolis, Minnesota
- Nebraska Medical Center — Omaha, Nebraska
- Duke University — Durham, North Carolina
- Temple University — Philadelphia, Pennsylvania
- Baylor Scott & White Research Institute — Dallas, Texas
- Baylor St. Luke's Medical Center — Houston, Texas
- Houston Methodist — Houston, Texas
- Medical College of Wisconsin — Milwaukee, Wisconsin
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Transplantation
- Inspiratory Muscle Training Immediately After Lung Transplantation — Columbus, Ohio
- Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies — Stanford, California
- Respiratory, Limb Muscle Properties, and Physical Performance in Adult Lung Transplant Recipients — Gainesville, Florida
- Transplanting Lungs From Uncontrolled Donation After Circulatory Death — New York, New York
- Trifecta-Lung cfDNA-MMDx Study — Phoenix, Arizona
Explore by condition: All Lung Transplantation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.